RecruitingISRCTN10232579
Psilocybin therapy after opioid detoxification: dose-finding and low-dose comparison
About this title
A trial to investigate if psilocybin therapy is effective in improving outcomes for people with opioid use disorder
Read the official source — ISRCTN10232579Research studyAges 18–64United KingdomAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 64 years.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Imperial College London
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- From 18 Years to 64 Years
- Official registry ID
- ISRCTN10232579
- Official title
Show the full official title
A trial to investigate if psilocybin therapy is effective in improving outcomes for people with Addiction
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Imperial College London, a university.
Who can participate?
Listed age limits: 18 years to 64 years.
Is this study still recruiting?
The registry lists this study as recruiting.
